Why CGM

Dexcom CGM helps your vulnerable pediatric patients with diabetes

Dexcom CGM helps your vulnerable pediatric patients with diabetes

American Dibetes Association

The 2026 ADA Guidelines recommend CGM like Dexcom G7 for all children with diabetes1

According to ADA Guidelines:

Patients should also monitor glucose metrics other than A1C or as soon as possible for glucose management in children and adolescents with diabetes who can use the device safely (either alone or with caregivers).1,2

Patients should also monitor glucose metrics other than A1C continuously and monitor their glucose levels multiple times throughout the day.1,2

 

Patients should also monitor glucose metrics other than A1C whenever possible, to gain additional useful insights and information.1,2

CGM can help. add a sense of independence for pediatric patients, and peace of mind for their caregivers and healthcare providers*,†,‡,3,4

 

BGM vs. CGM

CGM’s continuous 24-hour monitoring catches the spikes and lows that BGM may miss while building a picture of day-to-day trends5

 

same 24-hour day with BGM vs. Dexcom G7 15 Day - showing greater measurements with Dexcom G7 15 day

 

Illustrative model of a 24-hour blood glucose profile; not derived from an actual patient dataset.

Zoom in

Unlike BGM, CGM reveals glucose variability to help 
reduce excursions5

BGM: 3-5 readings a day

  • Provides 1 measurement at 1 point in time
  • Detects neither direction nor rate of glucose changes, nor trends
  • BGM may miss up to 98.3% of glucose readings daily§
  • Requires multiple fingersticks daily

CGM: 288 readings a day6

  • Predicts lows and may allow for corrective action5
  • Also tracks TIR and glucose variability6
  • Encourages positive diet and exercise changesII,7
  • Improves physician-patient partnership8

 

Clinical Burden

 

Pediatric patients with type 1 diabetes may experience unique clinical burdens

Pediatric patients with type 1 diabetes may experience unique clinical burdens

Some of the challenges pediatric patients with type 1 diabetes face that are different than adults include:

  • Unpredictable glucose levels with varying insulin needs due to hormones9
  • A need for frequent monitoring and treatment adjustments because of glucose variability, constant growth, and activity9
  • Difficulty articulating symptoms9
  • Cognitive dysfunction due to daily periods of hyper- and hypoglycemia9,10
  • Feeling different from peers11
  • Trips to the emergency room due to daily periods of hyper- and hypoglycemia12

 

Emotional Burden

 

Emotional stress and strain are common among caregivers of children with type 1 diabetes13

Emotional stress and strain are common among caregivers of children with type 1 diabetes13

Parents and caregivers worry constantly about their children with diabetes and may face challenges such as13:

  • Chronic sorrow
  • Increased anxiety
  • Feeling responsible for glucose highs and lows
  • Sleep disturbances
  • Career sacrifices
  • Difficulty navigating social experiences

Use of a CGM like Dexcom G7 for children with type 1 diabetes can help restore parents’ and caregivers’ peace of mind3

quality of life

Explore G7 CGM

See the features and outcomes for your pediatric patients with diabetes

View Now

currency

Coverage & 
Affordability

Extensive coverage through a broad range of commercial and Medicare plans¶,14,15

Learn more

Dexcom healthcare provider

Request a representative visit or G7 15 Day or G7 samples

Request Now

A1C=hemoglobin A1C; ADA=American Diabetes Association; AID=automated insulin delivery; BGM=blood glucose monitoring; CGM=continuous glucose monitoring; DKA=diabetic ketoacidosis; TIR=time in range.

*The only CGM system with app features that helps protect from severe hypoglycemia and DKA.4
†The only CGM system with a predictive Urgent Low Soon alert,‡ notifying you of a severe low up to 20 minutes before it happens.
‡Audible and visual notification of predictive alert at 55 mg/dL within 20 minutes.
§Based on a person testing blood glucose 5x a day vs. 288 readings using Dexcom CGM.
II55% of participants surveyed wore Dexcom CGM.
¶Individual pricing may vary. Coverage may vary by insurance.

References: 1. ADA PPC_7. Diabetes Care. 2026;49(Supp 1):S150-S165. 2. ADA PPC_14. Diabetes Care. 2026;49(Supp 1):S297-S320. 3. Polonsky WH, et al. J Diabetes Sci Technol. 2022;16(1):97-105. 4. Graham R, et al. Diabetes Technol Ther. 2024;26(1):24-32. 5. Pettus J, et al. J Diabetes Sci Technol. 2017;11(1):138-147. 6. Battelino T, et al. Diabetes Care. 2019;42(8):1593-1603. 7. Ehrhardt N, et al. Clin Diabetes. 2020;38(2):126-131. 8. Cowart K, et al. Expert Rev Med Devices. 2021;18(11):1049-1055. 9. Streisand R, et al. Curr Diabetes Rep. 2014;14(9):520. 10. Marzelli MJ, et al. Diabetes. 2014;63(1):343-353. 11. Lehmkuhl HD, et al. J Clin Psychol Med Settings. 2009;16(3):209-215. 12. Mulinacci G, et al. Diabetes Technol Ther. 2019;21(1):6-10. 13. Azimi T, et al. Heliyon. 2024;10(6):e27539. 14. Data on file, Dexcom. 2025.  15. Data on file, Dexcom. 2026.

MAT-16468